July 08, 2025

FIU Health Physicians to Practice Under Baptist Health as Part of FIU Clinical and Academic Alliance

Baptist Health and Florida International University (FIU) Herbert Wertheim College of Medicine have formed a strategic alliance that aims to enhance patient care, physician training and clinical research in South Florida.

Baptist Health South Florida

July 02, 2025

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer?

Patients with metastatic, castration-resistant prostate cancer (mCRPC) have a median overall survival of only about two to three years, but genomic sequencing is making inroads against that grim prognosis.

Roswell Park Comprehensive Cancer Center

July 01, 2025

AI-Enhanced PACT as a Noninvasive Breast Imaging Alternative

Panoramic photoacoustic computed tomography (PACT) with machine learning assistance could be a safe, noninvasive, and sensitive alternative to mammography, ultrasound, and MRI for breast cancer screen...

The ASCO Post

July 01, 2025

Dana-Farber Research News 07.01.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from June 1 through June 15.

Dana-Farber

June 30, 2025

Novel Cancer Screening Test for Veterans Now Being Offered at Dana-Farber Cancer Institute

During their time of service, members of the U.S. Armed Forces face considerable risks while fulfilling their mission and protecting the country. However, a less visible risk to the wellbeing of U.S. military members and veterans is on the rise.

Dana-Farber

June 27, 2025

Nearly 50% of All Cancer Deaths Worldwide Attributable to Modifiable Risk Factors

Tobacco and alcohol use, infections, excess body weight, unhealthy diet, physical inactivity, ultraviolet radiation exposure, environmental pollutants, and occupational exposures are all key contribut...

The ASCO Post

June 27, 2025

Botulinum Toxin and Scopolamine for Radiation-Induced Salivary Gland Toxicity in Metastatic Prostate Cancer

Injection with botulinum toxin type A plus transdermal scopolamine led to the reduction in radiation-induced salivary gland toxicity without compromising PSMA tumor uptake in patients with metastatic ...

The ASCO Post

June 25, 2025

Malignant Hematology Expert and Medicare Reimbursement Advocate, Samuel M. Silver, MD, PhD, FRCP, FASCO, MACP, Dies at 74

The ASCO Post would like to pay tribute to Samuel M. Silver, MD,PhD, FRCP, FASCO, MACP, who died on August 14, 2024, at the age of 74. Dr. Silver was renowned in the hematology and oncology community ...

The ASCO Post

June 25, 2025

William C. Wood, MD, FASCO, Renowned Surgeon, Esteemed Mentor, Global Academic Dean, Dies at 84

William C. “Bill” Wood, MD, FASCO, a leader and mentor in the field of breast cancer, died on August 18, 2024. He was 84.

The ASCO Post